换一批
换一批Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.
作者：
主题词
抗HIV药(Anti-HIV Agents);细胞系(Cell Line);抗药性, 病毒(Drug Resistance, Viral);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);表型(Phenotype);重组融合蛋白质类(Recombinant Fusion Proteins);结果可重复性(Reproducibility of Results);逆转录酶抑制剂(Reverse Transcriptase Inhibitors)
DOI
10.1002/jcla.22206
PMID
28303602
发布时间
2021-01-09
- 浏览17
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
